IndraLab

Statements

Ibrutinib inhibits NFKBIA. 1 / 1

| 1

reach

"After TCR stimulation in primary CD4 + T cells and Jurkat T cells, Ibrutinib inhibited activation of PLCgamma1, NFAT, JunB and IKBalpha which are ITK downstream targets [XREF_BIBR]."

27917390

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Ibrutinib inhibits NFKBIA. 1 / 1

INDRA sources:

Databases

Reading